Thyroid News

A cohort of adults with obesity or morbid obesity had a lower rate of papillary thyroid malignancy after thyroid surgery than adults without obesity, according to findings published in the Journal of Surgical Research.

An analysis of a cohort of adults with morbid obesity and primary hypothyroidism demonstrated that most were adequately treated with levothyroxine replacement therapy, with younger age and lower BMI predicting increased risk for overtreatment, according to findings from a cross-sectional study.

In patients with hyperthyroidism treated with radioactive iodine, organ-absorbed doses were associated with increased risk for death from all solid cancers, including breast cancer, according to study results published in JAMA Internal Medicine.

Endocrine Today has compiled a list of the top 10 news reports posted during the month of June.

Thyroid disease is the second most common endocrine disorder among women of reproductive age, and endocrinologists managing women with thyroid disease must consider several important points when developing a treatment plan before, during and after pregnancy, according to Caroline Nguyen, MD, assistant professor of clinical medicine at Keck School of Medicine at USC.

Among patients with low- or intermediate-risk differentiated thyroid cancer who underwent thyroidectomy, surveillance can safely be based on periodic serum thyroglobulin assays without the routine use of neck ultrasound if the initial imaging assessment reveals no evidence of disease, according to a retrospective analysis published in The Journal of Clinical Endocrinology & Metabolism.

A cohort of adults with primary hyperparathyroidism and depression experienced an improvement in both somatic and cognitive depressive symptoms after undergoing successful parathyroidectomy, regardless of the severity of disease at baseline, according to findings from a case-control study published in Clinical Endocrinology.

CHICAGO — Anthony “Andy” Boral, MD, PhD, chief medical officer at Blueprint Medicines, spoke with HemOnc Today at ASCO Annual Meeting about key study results the company presented and the investigational agents in its pipeline.

Adults with higher parathyroid hormone and lower vitamin D levels are more likely to experience an episode of atrial fibrillation compared with those with normal measures, according to findings published in Nutrition, Metabolism and Cardiovascular Diseases.

CHICAGO — BLU-667 demonstrated durable and potent antitumor activity among patients with RET-altered advanced medullary thyroid cancer or RET-fusion positive papillary thyroid cancer, according to results of the ARROW study presented at ASCO Annual Meeting.